Results 121 to 130 of about 21,844 (159)
Some of the next articles are maybe not open access.

Rubella and Mumps Vaccines

Pediatric Clinics of North America, 1990
As a fetal infection occurring during early pregnancy, rubella's potential for teratogenicity is unparalleled. In the postnatal period it is a relatively benign disease. Mumps, on the other hand, causes moderate morbidity and occasional mortality. Both infections cause considerable morbidity and disruption in the lives of young people gathered for ...
S S, Bakshi, L Z, Cooper
openaire   +2 more sources

Mumps Virus Vaccine

Pediatrics, 1969
For several years a number of pediatricians have been on an advisory committee on immunizations to the Montana State Board of Health. At the last meeting I was commissioned to write the Committee on Control of Infectious Diseases regarding the mumps virus vaccine and the recommendations which at that time had not been revised, but which subsequently ...
openaire   +2 more sources

Measles, Mumps, and Rubella Vaccines

Infectious Disease Clinics of North America, 1990
With widespread use of the live virus vaccines for measles, mumps, and rubella, there has been a dramatic decrease in the incidence of all three diseases. At the same time, an increasing proportion of the remaining cases are occurring in adolescents and adults. Thus, vaccinations for these three diseases of childhood must be included in a comprehensive
M, Wharton, S L, Cochi, W W, Williams
openaire   +2 more sources

CLINICAL MUMPS VACCINE EFFICACY

American Journal of Epidemiology, 1985
From February 5 through April 23, 1982, 110 cases of mumps were reported among 357 students in a middle school in Ashtabula County, Ohio, an overall attack rate of 31%. Vaccine efficacy was calculated using a variety of case definitions, case surveillance systems, and vaccination-status ascertainment methods to evaluate their effects on the estimated ...
R, Kim-Farley   +7 more
openaire   +2 more sources

Laboratory Tests of Mumps Vaccines

Biologicals, 1997
The action of live attenuated vaccines against mumps is poorly understood although their clinical efficacy is beyond doubt. The attenuated character of the vaccine is assured by consistency of production related to clinical trials, and limited studies of vaccine seeds in primates.
openaire   +2 more sources

Mumps Vaccine: Possible Reaction

Pediatrics, 1969
The following is a report of a reaction to the mumps vaccine, which has not been described before to the best of my knowledge. The patient, a healthy 12-year-old male, was given mumps vaccine (MUMPSVAX, Merck Sharp and Dohme) on January 9, 1969. Four days later he developed the following symptoms: dizziness, vomiting, extreme restlessness, and insomnia.
openaire   +2 more sources

Withdrawal of a mumps vaccine

European Journal of Pediatrics, 1994
A. Colville   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy